You are here
How to treat CML in 2017?
How to treat CML in 2017?
Andreas Hochhaus, Universitätsklinikum Jena, Germany
- Objectives of treatment optimization
- Choice of initial therapy
- Clinical data on 1st and 2nd generation TKI's
- Comorbidities in CML at diagnosis
- Main adverse events of TKI's
- ELN recommendations for monitoring of first-line TKI therapy
- Recommendations for switch: CP-CML
- Management of blast crisis
- Limitations of TKI therapies
- Discussion: are we ready for routine stopping procedure?
- Recommendations on CML management 2013 - 2017
This presentation is adapted from the one presented during the CML educational session at EHA. It lasts around 30 minutes.